AGIOS PHARMACEUTICALS INC (AGIO) Institutional Ownership and Insiders Activity
AGIOS PHARMACEUTICALS INC (AGIO) is widely held by institutional investors, with 231 firms reporting positions valued at approximately $2.28B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $239.58M in AGIO holdings in its latest filing.
Recent insider activity includes 3 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
231
Total Reported Value
$2.28B
Largest Holder
Blackrock, Inc.
Largest Position
$239.58M
Insider Transactions (90d)
3
Latest Filing Quarter
Q2 2026
New Institutional Positions
39
Funds Exiting Positions
38
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$239.58M
- State Street Corp$131.14M
- Lynx1 Capital Management Lp$126.51M
- D. E. Shaw & Co., Inc.$115.30M
- Vanguard Portfolio Management Llc$107.55M
Related AGIO Institutional Insights:
- AGIO 13F Institutional Holders
- AGIO Superinvestors
- AGIO Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- AGIO Insider Trading & SEC Form 4 Activity
- AGIO Articles
- Top Institutional Investor Stock Rankings